Diamedica Therapeutics Inc.

DMAC·NASDAQ·$6.32Share Price as of 11/2·$341MMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/10/26 10-QQ1 ended 03/31/2605/06/26 10-KFY 202503/30/26 10-QQ3 ended 09/30/2511/12/25 10-QQ2 ended 06/30/2508/12/25

Disclosures

8-KCurrent report08/10/26 8-KCurrent report05/21/26 8-KCurrent report05/06/26 8-KCurrent report03/31/26 8-KCurrent report01/05/26

Prospectuses and Registrations

S-8Registration of securities for employees08/11/26 S-8Registration of securities for employees11/13/25 424B2Prospectus for primary offering08/22/25 S-3Shelf registration08/12/25 S-3Shelf registration08/01/25

Proxies

DEF 14ADefinitive proxy04/01/26 DEFA14AAdditional proxy materials04/01/26 DEF 14ADefinitive proxy03/28/25 DEFA14AAdditional proxy materials03/28/25 DEF 14ADefinitive proxy04/04/24

Ownership

Form 4Insider transaction08/12/26 Form 4Insider transaction06/03/26 Form 4Insider transaction06/03/26 Form 4Insider transaction06/03/26 Form 4Insider transaction06/03/26

Other

ARSAnnual report to shareholders04/01/26 EFFECTRequest for effectiveness08/22/25 CORRESPCorrespondence with the SEC08/20/25 UPLOADLetter from the SEC08/18/25 EFFECTRequest for effectiveness08/08/25